Archive September 10, 2021 Deciphera Pharmaceuticals to Host Virtual Investor Event Featuring Key Opinion Leaders to Discuss Rebastinib and Vimseltinib Data Presented at ESMO Congress 2021
Archive September 2, 2021 Deciphera Pharmaceuticals, Inc. to Present at the 19th Annual Morgan Stanley Global Healthcare Conference
Archive August 3, 2021 Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2021 Financial Results
Archive July 27, 2021 Deciphera Pharmaceuticals to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 3, 2021
Archive June 30, 2021 Deciphera Announces First Patient Treated in Phase 1 Study of DCC-3116 in Patients with Advanced or Metastatic Tumors with a Mutant RAS or RAF Gene
Archive June 4, 2021 Deciphera Pharmaceuticals Presents Data from QINLOCK® and Rebastinib Programs at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
Archive April 27, 2021 Deciphera Pharmaceuticals to Announce First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 4, 2021
Archive March 2, 2021 Deciphera Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference